These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11257834)

  • 1. Smoking and renal cell carcinoma.
    Hogan TF; Lamm DL; Ducatman AM
    W V Med J; 2001; 97(1):32-5. PubMed ID: 11257834
    [No Abstract]   [Full Text] [Related]  

  • 2. Update on staging controversies for locally advanced renal cell carcinoma.
    Margulis V; Wood CG
    Expert Rev Anticancer Ther; 2007 Jul; 7(7):909-14. PubMed ID: 17627450
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic factors in renal cell cancer.
    Park WH; Eisen T
    BJU Int; 2007 May; 99(5 Pt B):1277-81. PubMed ID: 17441924
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal cell carcinoma: urologists in a new era.
    Uzzo RG
    J Urol; 2005 Nov; 174(5):1723-4. PubMed ID: 16217270
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of molecular markers in the staging of renal cell carcinoma.
    Leppert JT; Pantuck AJ; Figlin RA; Belldegrun AS
    BJU Int; 2007 May; 99(5 Pt B):1208-11. PubMed ID: 17441912
    [No Abstract]   [Full Text] [Related]  

  • 6. Collecting duct renal cell carcinoma: two different clinical stages, two different clinical outcomes.
    Vázquez-Lavista LG; Uribe-Uribe N; Gabilondo-Navarro F
    Urol Int; 2008; 81(1):116-8. PubMed ID: 18645283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [German Renal Cell Tumors Network].
    Junker K; Wunderlich H; Steiner T; Hartmann A; Schubert J
    Urologe A; 2007 Sep; 46(9):1166. PubMed ID: 17676297
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal cell carcinoma in the native and allograft kidneys of renal transplant recipients.
    Leveridge M; Musquera M; Evans A; Cardella C; Pei Y; Jewett M; Robinette M; Finelli A
    J Urol; 2011 Jul; 186(1):219-23. PubMed ID: 21575970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renal cell carcinoma in chronic hemodialysis patients].
    Imai K; Sekino H; Terasawa Y; Nakamura K
    Nihon Rinsho; 1992 Jan; 50 Suppl():848-54. PubMed ID: 1578777
    [No Abstract]   [Full Text] [Related]  

  • 10. Integrative tumor board: metastatic renal cell carcinoma: medical oncology (II).
    Pandha H
    Integr Cancer Ther; 2004 Mar; 3(1):29-34. PubMed ID: 15035872
    [No Abstract]   [Full Text] [Related]  

  • 11. [Problems in the therapy of kidney neoplasms].
    Masuda F
    Nihon Hinyokika Gakkai Zasshi; 1985 Nov; 76(11):1612-8. PubMed ID: 3835352
    [No Abstract]   [Full Text] [Related]  

  • 12. [Combination therapy of localized and locally-advanced renal-cell cancer using preoperative arterial embolization].
    Karelin MI; Atroshchenko AV; Shkol'nik MI; Leonenkov RV; Belov AD; Kharitonov MV
    Vopr Onkol; 2008; 54(1):95-7. PubMed ID: 18416067
    [No Abstract]   [Full Text] [Related]  

  • 13. Integrative tumor board: metastatic renal cell carcinoma: naturopathic medicine.
    Rubin D
    Integr Cancer Ther; 2004 Mar; 3(1):34-41. PubMed ID: 15035873
    [No Abstract]   [Full Text] [Related]  

  • 14. Tissue array-based predictions of pathobiology, prognosis, and response to treatment for renal cell carcinoma therapy.
    Lam JS; Belldegrun AS; Figlin RA
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6304S-9S. PubMed ID: 15448022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active and passive smoking and risk of renal cell carcinoma in Canada.
    Hu J; Ugnat AM;
    Eur J Cancer; 2005 Mar; 41(5):770-8. PubMed ID: 15763654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reporting standards for percutaneous thermal ablation of renal cell carcinoma.
    Clark TW; Millward SF; Gervais DA; Goldberg SN; Grassi CJ; Kinney TB; Phillips DA; Sacks D; Cardella JF
    J Vasc Interv Radiol; 2006 Oct; 17(10):1563-70. PubMed ID: 17056998
    [No Abstract]   [Full Text] [Related]  

  • 17. [A case report of chromophobe cell renal carcinoma arising from atrophic kidney during long-term haemodialysis].
    Onishi T; Igarashi T; Tobe T; Ichikawa T
    Hinyokika Kiyo; 2006 Dec; 52(12):919-21. PubMed ID: 17252973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NCCN practice guidelines for kidney cancer. National Comprehensive Cancer Network.
    Oncology (Williston Park); 1998 Nov; 12(11A):396-412. PubMed ID: 10028523
    [No Abstract]   [Full Text] [Related]  

  • 19. Metachronous bilateral renal cell carcinoma: risk assessment, prognosis and relevance of the primary-free interval.
    Klatte T; Patard JJ; Wunderlich H; Goel RH; Lam JS; Junker K; Schubert J; Böhm M; Allhoff EP; Kabbinavar FF; Crepel M; Cindolo L; De La Taille A; Tostain J; Mejean A; Soulie M; Bellec L; Bernhard JC; Ferriere JM; Pfister C; Albouy B; Colombel M; Zisman A; Belldegrun AS; Pantuck AJ
    J Urol; 2007 Jun; 177(6):2081-6; discussion 2086-7. PubMed ID: 17509291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
    Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
    J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.